Utility of Urinary Biomarkers for Diagnosis of Acute Kidney Injury (AKI) in COVID-19
- 13 March 2024
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 40 (4) , 1-8
Abstract
Acute kidney injury (AKI) is a complication of COVID-19 and urinary biomarkers of renal “stress” and “injury” can be utilised for an early diagnosis. In this prospective observational study, critically-ill adult patients with COVID-19 disease from November 2020 to May 2021 were recruited and urine samples collected at the time of admission to ICU, and subsequently at 12, 24 and 48 h and analysed for biomarkers of “renal injury” namely KIM-1, NGAL, IL-18, and cell cycle arrest biomarker IGFBP-7 and TIMP-2 which have been reported to increase following renal stress. Spot urine samples were collected and to adjust for dilution, sample volume and rate of urine production, assays of the biomarkers were normalised by dividing the values with urinary creatinine concentration. The incidence of AKI in our study was 22.64% (24/106). Patients in the AKI group were older with significantly higher requirements for invasive mechanical ventilation, inotropic support, longer hospital stay, and higher mortality. Diagnostic performance of various biomarkers to predict AKI was compared with receiver operator characteristics curve analysis. TIMP-2 × IGFBP7 > 0.301 (ng/ml)2/1000 predicted AKI with sensitivity and specificity of 84.1% and 31.6% (AUC = 0.579, and p < 0.035), respectively. AUC was 0.663 with a p-value < 0.001 when cut-off values after normalisation were > 0.87 (ng/mmol)2/1000. IL-18, TIM-1, NGAL predicted AKI at cut-off values of 24.936, 12,372.766, and 8017.74 ng/mmol with AUC of 0.653 (p ≤ 0.001), 0.646 (p ≤ 0.001), and 0.552 (p = 0.035), respectively. Urinary cell cycle arrest biomarkers have a more promising role over biomarkers of renal injury in identification of patients at risk of AKI.Keywords
Funding Information
- Postgraduate Institute of Medical Education and Research, Chandigarh (IM/42/11-05-21-0046)
This publication has 12 references indexed in Scilit:
- Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 PatientsDiagnostics, 2023
- Biochemical Predictors of Acute Kidney Injury in Critically Ill COVID-19 PatientsOMICS: A Journal of Integrative Biology, 2022
- Urinary Tubular Biomarkers As Predictors of Death in Critically Ill Patients with Covid-19Biomarkers in Medicine, 2022
- Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 PatientsBiomolecules, 2022
- Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19Kidney International Reports, 2021
- Acute kidney injury and urinary biomarkers in hospitalized patients with coronavirus disease-2019Nephrology Dialysis Transplantation, 2020
- NGAL for the Detection of Acute Kidney Injury in the Emergency RoomBiomarkers in Medicine, 2014
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Some biomarkers of acute kidney injury are increased in pre-renal acute injuryKidney International, 2012
- Test Characteristics of Urinary Biomarkers Depend on Quantitation Method in Acute Kidney InjuryJournal of the American Society of Nephrology, 2012